Skip to the main content.

Provider Sign In

Heart Disease Technology
- Cleerly Technology
- Clinical Evidence
Heart Disease Solutions for...
About
- Leadership
- Blog
- Newsroom
  - Press Releases
  - In The News
- Events
- Support
- Careers
Contact
Find Cleerly Near You

Search

Heart Disease Technology
- Cleerly Technology
- Clinical Evidence
Heart Disease Solutions for...
About
- Leadership
- Blog
- Newsroom
  - Press Releases
  - In The News
- Events
- Support
- Careers
Contact
Find Cleerly Near You

Careers

You. Belong. Here.

Explore This Opportunity

Connect With Us to Learn More

Subscribe to receive Cleerly news, product information, and upcoming events.

Patents

Cleerly continues to revolutionize heart attack and cardiovascular disease prevention and treatment everyday by inventing world-class technology. Cleerly invests significant time and resources in research and development towards this goal. To protect Cleerly’s research and development efforts, Cleerly has vigorously developed a robust intellectual property portfolio – all part of a strategy for protecting the innovations that make Cleerly an industry leader in cardiovascular disease prevention and treatment.

Cleerly’s products and services may be covered by or for use under one or more of U.S. Patent Nos. 11,922,627, 11,948,301, 12,023,190, 11,861,833, 11,967,078, 11,832,982, 11,690,586, 11,779,292, 11,730,437, 11,672,497, 11,737,718, 11,751,826, 11,660,058, 11,896,415, 11,751,830, 11,751,829, 11,302,001, 11,308,617, 11,238,587, 11,302,002, 11,321,840, 11,341,644, 11,244,451, 11,288,799, 11,276,170, 11,210,786, 11,232,564, 11,367,190, 11,315,247, 11,969,280, 11,094,060, 11,120,550, 11,120,549, 11,132,796, 11,094,061, 11,113,811, 11,501,436, 11,751,831, 11,642,092, 11,759,161, 11,317,883, 11,350,899, 11,766,230, 11,766,229, and 10,813,612, as well as other patents that are pending.

For additional information, please contact legal@cleerlyhealth.com.

Solutions

Individuals
Providers
Payers

About

Leadership
Events
News
Careers

Terms & Conditions
Indications for Use
Privacy Policy
Patents